Credits: Photo courtesy of SMART. Caption: A closeup of the SMART microfluidic DLD assay chip with a Singapore $1 coin for scale Credits: Photo courtesy of SMART. Caption: Experiment flow on the microfluidic DLD assay chip with sample red dye loaded on a microscope stage Credits: Photo courtesy of SMART.
Previous image
Next image
Researchers from Critical Analytics for Manufacturing Personalized-Medicine (CAMP), an interdisciplinary research group at the Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, have developed a new label-free immune profiling assay that profiles the rapidly changing host immune response in case of infection, in a departure from existing methods that focus on detecting the pathogens themselves, which can often be at low levels within a host. This novel technology presents a host of advantages over current methods, being much faster, more sensitive, and more accurate.